Approval

Eisai Submits Application in Europe Seeking Approval for Fycompa as Treatment for Pediatric Patients With Epilepsy

New Delhi, Febraury 14, 2019:  Eisai Co., Ltd. announced today that it has submitted an application to the European Medicines Agency…

6 years ago

Wockhardt Receives US FDA Approval for Leukemia drug

 Mumbai, January 27, 2019: Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US…

6 years ago

US FDA accepts regulatory submissions for review of tafamidis to treat transthyretin amyloid cardiomyopathy

New Delhi, January 16, 2019: Pfizer Inc. announced today that the US Food and Drug Administration (FDA) accepted for filing…

6 years ago

ICRA assigns stable outlook for Indian Pharma companies

New Delhi, January 04, 2018: ICRA has given a stable outlook on the Indian pharmaceutical industry. The headwinds from pricing pressure in…

6 years ago

CPhI Annual report forecasts CMOs to benefit from double digit approvals for ADCs in the next 3-years.

Novel payloads that target tumour-initiating cells on third generation ADCs could come to market in the next couple of years…

6 years ago

WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China

Shanghai, November 15, 2018: WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of Fruquintinib capsules (Elunate®) for metastatic…

6 years ago

Aurobindo Pharma gets nod from South African health authority for HIV drug

New Delhi, September 19, 2018: The Hyderabad-based drug firm said it has received approval from the South African Health Products…

6 years ago

WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China

Shanghai, September 09, 2018: WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of Fruquintinib capsules (Elunate®) for metastatic…

6 years ago

Eisai’s LENVIMA (LENVATINIB) Capsules Approved for First-Line Treatment of Unresectable Hepatocellular Carcinoma (HCC) in South Korea

Tokyo, Septembe 02, 2018: Eisai Co., Ltd. announced that its South Korea subsidiary Eisai Korea Inc. received approval for the…

6 years ago

Cipla Receives Final Approval for Generic Voltaren® Gel (Diclofenac Sodium Topical Gel, 1%)

Mumbai, August 10, 2018: Cipla Limited (“Cipla”) announced that it has received final approval on August 3, 2018, for its…

6 years ago